MIRA Pharmaceuticals, Inc.
MIRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,833 | $4,603 | $351 | $2,810 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $55 | $256 | $143 | $100 |
| Total Curr. Assets | $2,888 | $4,858 | $494 | $2,910 |
| Property Plant & Equip (Net) | $0 | $5 | $364 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $35 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $69 | $0 | $446 |
| Total NC Assets | $35 | $74 | $364 | $446 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,923 | $4,932 | $858 | $3,355 |
| Liabilities | – | – | – | – |
| Payables | $723 | $539 | $906 | $228 |
| Short-Term Debt | $0 | $5 | $407 | $293 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $14 | $58 | $572 |
| Total Curr. Liab. | $723 | $558 | $1,370 | $1,094 |
| LT Debt | $0 | $0 | $84 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | -$0 | $0 | $0 |
| Total NC Liab. | $0 | -$0 | $84 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $5 | $358 | $0 |
| Total Liabilities | $723 | $558 | $1,454 | $1,094 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $1 | $7 | $6 |
| Retained Earnings | -$29,138 | -$21,285 | -$9,303 | -$2,245 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $31,336 | $25,658 | $8,700 | $4,500 |
| Total Equity | $2,200 | $4,374 | -$596 | $2,261 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,923 | $4,932 | $858 | $3,355 |
| Net Debt | -$2,833 | -$4,598 | $140 | -$2,516 |